Yale Weekly Newsletter
By The Petrie-Flom Center Check out the latest edition of the weekly Yale Interdisciplinary Center for Bioethics newsletter. For the full Friday newsletter archive, see their website.
Author
By The Petrie-Flom Center Check out the latest edition of the weekly Yale Interdisciplinary Center for Bioethics newsletter. For the full Friday newsletter archive, see their website.
By The Petrie-Flom Center Aaron Kesselheim is a physician and an Assistant Professor of Medicine at the Harvard Medical School. He will be speaking at the Petrie-Flom Health Law Workshop on Monday, November 18, at 5:00pm, on…
On Friday, October 4, the Tulsa Law Review hosted a symposium titled “Health Law Policy: Legal Issues in the Evolving Healthcare Market” honoring the work of Petrie-Flom Center Founding Director Einer Elhauge. I. Glenn Cohen, current Faculty Co-Director of the Petrie-Flom…
By The Petrie-Flom Center Please join the Petrie-Flom Center for a lecture by Neil Flanzraich on responsible pricing strategy, access to care, clinical trial design, outsourcing, and other topics that raise thorny but crucial issues for pharmaceutical…
By Melissa Lopes Paul Appelbaum’s keynote address was both reflective and forward-looking in nature. He reflected back on his late ‘80s groundbreaking research introducing the concept of “therapeutic misconception” and challenged the audience to apply the…
Health Law Opportunities at Harvard Law School Friday, November 15, 2013 12:00 PM Wasserstein Hall 3019 1585 Massachusetts Ave., Cambridge, MA 1Ls and 2Ls will have the opportunity to learn more about different classes and…
Video of the lecture is now available online. By Chloe Reichel Last Friday, Princeton ethicist Peter Singer joined Petrie-Flom for a lecture on “Ethics and Animals: Where are we now?” Singer began his talk with…
For more information, visit the STS website.
By The Petrie-Flom Center Applications for the Petrie-Flom Center 2014-2016 Academic Fellowships are due on November 18, 2013. (Please note that applications submitted before November 18 will not be reviewed early.) PURPOSE: The Academic Fellowship is a postdoctoral…
By Richard Epstein Bad News On December 14, 2012, the US Food and Drug Administration granted an accelerated approval to the drug Ponatinib, which is used to treat patients with serious and life threatening forms…